<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Liu X</submitter><funding>American Cancer Society</funding><funding>NCATS NIH HHS</funding><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Cancer Institute</funding><funding>U.S. Department of Defense</funding><funding>NCI NIH HHS</funding><funding>U.S. Department of Health &amp;amp; Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute</funding><funding>NIGMS NIH HHS</funding><funding>Cancer Prevention and Research Institute of Texas</funding><pagination>1721-1735</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9674084</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>54(11)</volume><pubmed_abstract>Histone post-translational modifications (PTMs) are important for regulating various DNA-templated processes. Here, we report the existence of a histone PTM in mammalian cells, namely histone H3 with hydroxylation of proline at residue 16 (H3P16oh), which is catalyzed by the proline hydroxylase EGLN2. We show that H3P16oh enhances direct binding of KDM5A to its substrate, histone H3 with trimethylation at the fourth lysine residue (H3K4me3), resulting in enhanced chromatin recruitment of KDM5A and a corresponding decrease of H3K4me3 at target genes. Genome- and transcriptome-wide analyses show that the EGLN2-KDM5A axis regulates target gene expression in mammalian cells. Specifically, our data demonstrate repression of the WNT pathway negative regulator DKK1 through the EGLN2-H3P16oh-KDM5A</pubmed_abstract><journal>Nature genetics</journal><pubmed_title>Histone H3 proline 16 hydroxylation regulates mammalian gene expression.</pubmed_title><pmcid>PMC9674084</pmcid><funding_grant_id>R01 CA215284</funding_grant_id><funding_grant_id>R01CA215284</funding_grant_id><funding_grant_id>1R35CA197684</funding_grant_id><funding_grant_id>RSG-18-059-01-TBE</funding_grant_id><funding_grant_id>R01CA211336</funding_grant_id><funding_grant_id>R01CA211732</funding_grant_id><funding_grant_id>R01 CA211336</funding_grant_id><funding_grant_id>UL1 TR001863</funding_grant_id><funding_grant_id>R01 CA211732</funding_grant_id><funding_grant_id>R01CA256833</funding_grant_id><funding_grant_id>DoD W81XWH1910813</funding_grant_id><funding_grant_id>R01 CA256833</funding_grant_id><funding_grant_id>1R35GM126900</funding_grant_id><funding_grant_id>R35 GM126900</funding_grant_id><funding_grant_id>R35 CA197684</funding_grant_id><funding_grant_id>RR190058</funding_grant_id><pubmed_authors>Boyer JA</pubmed_authors><pubmed_authors>Strahl BD</pubmed_authors><pubmed_authors>Guo Y</pubmed_authors><pubmed_authors>Wu Q</pubmed_authors><pubmed_authors>Rodriguez J</pubmed_authors><pubmed_authors>Tsai YH</pubmed_authors><pubmed_authors>Uryu H</pubmed_authors><pubmed_authors>Liao C</pubmed_authors><pubmed_authors>Wang J</pubmed_authors><pubmed_authors>Shi X</pubmed_authors><pubmed_authors>Zhang Q</pubmed_authors><pubmed_authors>Gong W</pubmed_authors><pubmed_authors>Liu X</pubmed_authors><pubmed_authors>Zhao S</pubmed_authors><pubmed_authors>Chen X</pubmed_authors><pubmed_authors>Baldwin AS</pubmed_authors><pubmed_authors>Zhang C</pubmed_authors><pubmed_authors>Zhou J</pubmed_authors><pubmed_authors>Yan Q</pubmed_authors><pubmed_authors>Xie L</pubmed_authors><pubmed_authors>Jain K</pubmed_authors><pubmed_authors>Li M</pubmed_authors><pubmed_authors>von Kriegsheim A</pubmed_authors><pubmed_authors>Luo W</pubmed_authors><pubmed_authors>Hu L</pubmed_authors><pubmed_authors>Wang GG</pubmed_authors></additional><is_claimable>false</is_claimable><name>Histone H3 proline 16 hydroxylation regulates mammalian gene expression.</name><description>Histone post-translational modifications (PTMs) are important for regulating various DNA-templated processes. Here, we report the existence of a histone PTM in mammalian cells, namely histone H3 with hydroxylation of proline at residue 16 (H3P16oh), which is catalyzed by the proline hydroxylase EGLN2. We show that H3P16oh enhances direct binding of KDM5A to its substrate, histone H3 with trimethylation at the fourth lysine residue (H3K4me3), resulting in enhanced chromatin recruitment of KDM5A and a corresponding decrease of H3K4me3 at target genes. Genome- and transcriptome-wide analyses show that the EGLN2-KDM5A axis regulates target gene expression in mammalian cells. Specifically, our data demonstrate repression of the WNT pathway negative regulator DKK1 through the EGLN2-H3P16oh-KDM5A</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2025-04-19T17:18:41.194Z</modification><creation>2025-02-19T03:25:55.338Z</creation></dates><accession>S-EPMC9674084</accession><cross_references><pubmed>36347944</pubmed><doi>10.1038/s41588-022-01212-x</doi></cross_references></HashMap>